Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,517,102
+$2,318,667 QoQ
Shares Held
29,753
+212.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Beacon Pointe Advisors, LLC holds $6,694,336 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (52.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
29,753 | $3,517,102 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,417 | $1,433,232 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
32,930 | $609,863 | |
| 4 | HLN |
Haleon plc
|
48,499 | $485,474 | |
| 5 | VTRS |
Viatris Inc
|
27,557 | $372,295 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,075 | |
| 7 | BTAI |
BioXcel Therapeutics, Inc.
|
18,877 | $25,295 |
All Filings in ZTS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,517,102 | 29,753 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,198,435 | 9,525 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,345,851 | 9,198 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,567,921 | 10,054 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,835,682 | 11,149 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,382,135 | 8,483 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,959,856 | 10,031 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,383,179 | 13,747 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,520,721 | 14,897 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,129,301 | 15,855 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,853,272 | 16,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,716,933 | 9,970 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,903,740 | 11,438 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,475,172 | 10,066 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,115,640 | 27,754 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,529,357 | 32,168 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,091,540 | 69,418 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $3,044,274 | 12,475 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,275,366 | 27,173 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,388,576 | 12,817 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $482,046 | 3,061 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $335,137 | 2,025 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||